The modified T-VEC cannot replicate in normal cells, but it can proliferate in tumor cells and finally lyse them, express the immune activation protein granulocyte-macrophage stimulating factor (GM-CSF), and accelerate the anti-tumor immune response. This evidence concerns the gene CSF2 and neoplasm.